View graph of relations

    Research Statement

    The Stratified Medicine Group focuses on the following areas:

    1) Characterisation of a molecular group in solid cancers that represents an innate immune response to DNA damage through the STING pathway.

    2) Development of a biomarker for anti-angiogenic agents

    3) Development of a biomarker for MEKK pathway activation

    4) Identification of a prognostic biomarker for early prostate cancer

    5) Development of new cell lines for pre-clinical modelling of ovarian and prostate cancer.



    Linked in Profile:


    Frequent Journals

    • Journal of Clinical Oncology

      ISSNs: 0732-183X, 1527-7755

      Additional searchable ISSN (Electronic): 1527-7755

      American Society of Clinical Oncology

      Scopus rating (2018): CiteScore 11.08 SJR 11.754 SNIP 5.223


    • Cancer Research

      ISSNs: 0008-5472

      Additional searchable ISSN (Electronic): 1538-7445

      American Association for Cancer Research Inc.

      Scopus rating (2018): CiteScore 6.94 SJR 4.047 SNIP 1.596


    • Oncotarget

      ISSNs: 1949-2553

      Impact Journals

      Scopus rating (2018): SJR 1.575 SNIP 0.904


    • Oncogene

      ISSNs: 0950-9232

      Additional searchable ISSN (Electronic): 1476-5594

      Nature Publishing Group

      Scopus rating (2018): SJR 3.127 SNIP 1.508


    • Molecular Cancer Therapeutics

      ISSNs: 1535-7163

      Additional searchable ISSN (Electronic): 1538-8514

      American Association for Cancer Research Inc.

      Scopus rating (2018): CiteScore 5.25 SJR 2.536 SNIP 1.192


    View all »

    ID: 26639